Copegus and Desloratadine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Copegus (ribavirin) and Desloratadine (desloratadine). Common drug interactions include abdominal pain among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Copegus and Desloratadine. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Copegus?
Copegus has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 15,115 Copegus users. Check the latest studies of Copegus.
What is Desloratadine?
Desloratadine has active ingredients of desloratadine. It is often used in allergies. eHealthMe is studying from 4,207 Desloratadine users. Check the latest studies of Desloratadine.
12 people who take Copegus and Desloratadine together, and have interactions are studied.

What are the common drug interactions of Copegus and Desloratadine, by gender? *:
female:
- Abdominal pain
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Vomiting
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Ileitis (inflammation of the ileum)
- Anaemia (lack of blood)
- Panniculitis (inflammation of the subcutaneous fat)
male:
- Diarrhoea
- Multi-organ failure (multisystem organ failure)
- Insomnia (sleeplessness)
- Oedema peripheral (superficial swelling)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pruritus (severe itching of the skin)
- Rash
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Nausea (feeling of having an urge to vomit)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
What are the common drug interactions of Copegus and Desloratadine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Depression
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
50-59:
- Anaemia (lack of blood)
- Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
- Insomnia (sleeplessness)
- Oedema peripheral (superficial swelling)
- Pruritus (severe itching of the skin)
- Rash
60+:
- Abdominal pain
- Dehydration (dryness resulting from the removal of water)
- Post thrombotic syndrome (long-term effects that can occur after venous thrombosis)
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Vomiting
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Ileitis (inflammation of the ileum)
- Anaemia (lack of blood)
What are the existing conditions these people have? *
- Anaemia (lack of blood): 5 people, 41.67%
- High Blood Pressure: 5 people, 41.67%
- The Flu (the flu is caused by an influenza virus): 4 people, 33.33%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 33.33%
- Itching: 3 people, 25.00%
- Diarrhea: 3 people, 25.00%
- Allergic Rhinitis: 3 people, 25.00%
- Nausea And Vomiting: 3 people, 25.00%
- Neck Pain: 3 people, 25.00%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Copegus and Desloratadine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Copegus (15,115 reports)
- Desloratadine (4,207 reports)
Browse all drug interactions of Copegus and Desloratadine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Copegus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Desloratadine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Copegus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Desloratadine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
- Lin SY, Lin CL, Ju SW, Wang IK, Lin CC, Lin CH, Hsu WH, Liang JA, "Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study", PloS one, 2017 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on ribavirin and desloratadine (the active ingredients of Copegus and Desloratadine, respectively), and Copegus and Desloratadine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Prozac and Coq10 - now
- Could Profen cause Personality Disorder? - 9 seconds ago
- Could Methylprednisolone Sodium Succinate cause Stable Angina? - 20 seconds ago
- Could Ms Contin cause Sepsis? - 28 seconds ago
- Drug interactions of Aleve and Ursodiol - 34 seconds ago
- Sertraline and Alcohol Use for Men aged 30-39 - 39 seconds ago
- Sertraline and Alcohol Detoxification for Men aged 30-39 - 40 seconds ago
- Sertraline and Alcohol Problem for Men aged 30-39 - 40 seconds ago
- Sertraline and Alcohol Rehabilitation for Men aged 30-39 - 40 seconds ago
- Sertraline and Alcohol Dependence for Men aged 30-39 - 40 seconds ago